Biodexa Pharmaceuticals Plc (BDRX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$4.17
+5.28%
Mkt Cap $796.85K
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 27, 2026 | — | — | — | -$0.01 | -$0.00 | +91.39% |
| Q3 2025 Sep 12, 2025 | — | — | — | -$0.00 | -$0.00 | +93.20% |
| Q2 2025 Apr 11, 2025 | $16.61K | — | — | -$0.01 | -$0.01 | -5.25% |
| Q3 2024 Sep 26, 2024 | $16.61K | — | — | -$0.22 | -$0.33 | -49.84% |
| Q2 2024 Apr 19, 2024 | $105.79K | $106.02K | +0.22% | -$3.54 | -$3.54 | -0.08% |
| Q3 2023 Sep 15, 2023 | — | $377.37K | — | — | -$2773.25 | — |
| Q2 2023 Apr 28, 2023 | — | $283.92K | — | — | -$36466.50 | — |
| Q3 2022 Sep 14, 2022 | — | $568.09K | — | — | -$23986.00 | — |
| Q2 2022 Apr 26, 2022 | — | $238.76K | — | — | -$20085.40 | — |
| Q3 2021 Sep 17, 2021 | — | $554.08K | — | — | -$28132.40 | — |
| Q2 2021 Apr 30, 2021 | — | $238.04K | — | — | -$41882.00 | — |
| Q3 2020 Sep 10, 2020 | — | $216.13K | — | — | -$16467.20 | — |
| Q4 2019 Dec 31, 2019 | — | $284.55K | — | — | -$195.27 | — |
| Q3 2019 Sep 30, 2019 | $651.00K | $557.00K | -14.44% | — | -$492.92 | — |
| Q2 2019 Apr 24, 2019 | — | $1.87M | — | — | -$4081250.00 | — |
| Q2 2018 Jun 30, 2018 | — | $721.25K | — | — | -$2384.03 | — |
| Q4 2017 Dec 31, 2017 | — | $693.69K | — | — | -$2460.82 | — |
| Q2 2017 Jun 30, 2017 | — | $612.66K | — | — | -$2524.45 | — |
| Q4 2016 Dec 31, 2016 | — | -$4.44M | — | — | $3179.24 | — |
| Q2 2016 Jun 30, 2016 | — | $3.93M | — | — | -$3529.39 | — |
| Q4 2015 Dec 31, 2015 | — | $1.55M | — | — | -$2486.36 | — |
| Q2 2015 Jun 30, 2015 | — | $505.99K | — | — | -$2467.88 | — |
| Q4 2014 Dec 31, 2014 | — | $194.27K | — | — | -$2988.23 | — |
| Q2 2014 Jun 30, 2014 | — | $61.74K | — | — | -$1549.45 | — |
| Q4 2013 Dec 31, 2013 | — | $212.94K | — | — | -$1045.00 | — |
| Q2 2013 Jun 30, 2013 | — | $24.45K | — | — | -$1032.60 | — |
| Q4 2012 Dec 31, 2012 | — | — | — | — | -$1008.32 | — |
| Q2 2012 Jun 30, 2012 | — | — | — | — | -$1006.14 | — |